Inhibition of BMP-induced ectopic bone formation by an antiangiogenic agent (epigallocatechin 3-gallate)

被引:29
作者
Takita, H [1 ]
Kikuchi, M [1 ]
Sato, Y [1 ]
Kuboki, Y [1 ]
机构
[1] Hokkaido Univ, Grad Sch Dent Med, Dept Oral Hlth Sci, Kita Ku, Sapporo, Hokkaido 0608586, Japan
关键词
epigallocatechin; BMP; angiogenesis; osteogenesis; chondrogenesis;
D O I
10.1080/03008200290000772
中图分类号
Q2 [细胞生物学];
学科分类号
071009 [细胞生物学]; 090102 [作物遗传育种];
摘要
Epigallocatechin 3-gallate (EGCG), which is one of the components of green tea, was recently shown to inhibit endothelial cell growth in vitro and angiogenesis in vivo [5]. We have previously shown that bone and cartilage formation by bone morphogenetic protein (BMP) is highly dependent on the geometry of the carrier (vasculature-inducing or -inhibiting geometry [2]. To verify the function of angiogenesis in the BMP induction system, we examine in this article whether inhibition ofangiogenesis enhances chondrogenesis and suppresses osteogenesis. Fibrous glass membrane used as a BMP carrier was mixed with 1.2 mug rhBMP-2 and 1-10 mug of EGCG and was implanted into rats subcutaneously. As the dose of EGCG increased, alkaline phosphatase activity and calcium content were decreased, whereas the type II collagen content was increased. The results clearly indicated that inhibition of vascularization enhanced chondrogenesis and suppressed osteogenesis.
引用
收藏
页码:520 / 523
页数:4
相关论文
共 15 条
[1]
Angiogenesis inhibited by drinking tea [J].
Cao, YH ;
Cao, RH .
NATURE, 1999, 398 (6726) :381-381
[2]
Garbisa S, 2001, CANCER-AM CANCER SOC, V91, P822, DOI 10.1002/1097-0142(20010215)91:4<822::AID-CNCR1070>3.0.CO
[3]
2-G
[4]
Jin QM, 2000, J BIOMED MATER RES, V51, P491, DOI 10.1002/1097-4636(20000905)51:3<491::AID-JBM25>3.0.CO
[5]
2-1
[6]
Two distinctive BMP-carriers induce zonal chondrogenesis and membranous ossification, respectively; Geometrical factors of matrices for cell-differentiation [J].
Kuboki, Y ;
Saito, T ;
Murata, M ;
Takita, H ;
Mizuno, M ;
Inoue, M ;
Nagai, N ;
Poole, AR .
CONNECTIVE TISSUE RESEARCH, 1995, 32 (1-4) :219-226
[7]
Kuboki Y, 1998, J BIOMED MATER RES, V39, P190, DOI 10.1002/(SICI)1097-4636(199802)39:2<190::AID-JBM4>3.0.CO
[8]
2-K
[9]
KUBONISHI I, 1983, International Journal of Cell Cloning, V1, P105
[10]
Antiangiogenic agent (TNP-470) inhibition of ectopic bone formation induced by bone morphogenetic protein-2 [J].
Mori, S ;
Yoshikawa, H ;
Hashimoto, J ;
Ueda, T ;
Funai, H ;
Kato, M ;
Takaoka, K .
BONE, 1998, 22 (02) :99-105